Search research articles
Contact Us
Filters
Showing results (111-120 of 128) with videos related to
Page
of 13
Sort By:
Health Technology Assessment (Winchester, England)
|
October 30, 2019
Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA<sup>2</sup> five-stage study, including a workshop
Jonathan A Cook, Steven A Julious, William Sones, et al.
The Lancet. Respiratory Medicine
|
January 27, 2022
SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys
Marc Chadeau-Hyam, Haowei Wang, Oliver Eales, et al.
Pharmacoepidemiology and Drug Safety
|
July 22, 2014
Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology
Christine E Hallgreen, Hendrika A van den Ham, Shahrul Mt-Isa, et al.
Microbial Genomics
|
February 6, 2023
The use of representative community samples to assess SARS-CoV-2 lineage competition: Alpha outcompetes Beta and wild-type in England from January to March 2021
Oliver Eales, Andrew J Page, Sonja N Tang, et al.
Gut
|
December 16, 2014
Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults
Edward S Chambers, Alexander Viardot, Arianna Psichas, et al.
Standards in Genomic Sciences
|
August 21, 2013
Meeting report: 1st international functional metagenomics workshop may 7-8, 2012, st. Jacobs, ontario, Canada
Katja Engel, Deborah Ashby, Sean F Brady, et al.
BMJ (Clinical Research Ed.)
|
October 20, 2023
Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance
Christina Yap, Olga Solovyeva, Johann de Bono, et al.
BMJ (Clinical Research Ed.)
|
October 20, 2023
Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance
Christina Yap, Jan Rekowski, Moreno Ursino, et al.
JAMA
|
July 2, 2009
Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease
Paul Elliott, John C Chambers, Weihua Zhang, et al.
BMJ (Clinical Research Ed.)
|
March 3, 2021
SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study
Maya Moshe, Anna Daunt, Barnaby Flower, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 128) with videos related to
Sort By:
Page
of 13
Health Technology Assessment (Winchester, England)
|
October 30, 2019
Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA<sup>2</sup> five-stage study, including a workshop
Jonathan A Cook, Steven A Julious, William Sones, et al.
The Lancet. Respiratory Medicine
|
January 27, 2022
SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys
Marc Chadeau-Hyam, Haowei Wang, Oliver Eales, et al.
Pharmacoepidemiology and Drug Safety
|
July 22, 2014
Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology
Christine E Hallgreen, Hendrika A van den Ham, Shahrul Mt-Isa, et al.
Microbial Genomics
|
February 6, 2023
The use of representative community samples to assess SARS-CoV-2 lineage competition: Alpha outcompetes Beta and wild-type in England from January to March 2021
Oliver Eales, Andrew J Page, Sonja N Tang, et al.
Gut
|
December 16, 2014
Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults
Edward S Chambers, Alexander Viardot, Arianna Psichas, et al.
Standards in Genomic Sciences
|
August 21, 2013
Meeting report: 1st international functional metagenomics workshop may 7-8, 2012, st. Jacobs, ontario, Canada
Katja Engel, Deborah Ashby, Sean F Brady, et al.
BMJ (Clinical Research Ed.)
|
October 20, 2023
Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance
Christina Yap, Olga Solovyeva, Johann de Bono, et al.
BMJ (Clinical Research Ed.)
|
October 20, 2023
Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance
Christina Yap, Jan Rekowski, Moreno Ursino, et al.
JAMA
|
July 2, 2009
Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease
Paul Elliott, John C Chambers, Weihua Zhang, et al.
BMJ (Clinical Research Ed.)
|
March 3, 2021
SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study
Maya Moshe, Anna Daunt, Barnaby Flower, et al.
Page
of 13